These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 16201086

  • 1. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
    Chiba T, Kudara N, Sato M, Chishima R, Abiko Y, Inomata M, Orii S, Suzuki K.
    Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086
    [Abstract] [Full Text] [Related]

  • 2. Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarbophil.
    Chiba T, Sato K, Toya Y, Endo K, Abiko Y, Kasugai S, Saito S, Oana S, Kudara N, Endo M, Suzuki K.
    Hepatogastroenterology; 2011; 58(110-111):1527-30. PubMed ID: 21940313
    [Abstract] [Full Text] [Related]

  • 3. [Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)].
    Iwanaga Y.
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):185-90. PubMed ID: 11915521
    [Abstract] [Full Text] [Related]

  • 4. [Effect of polycarbophil Ca on IBS].
    Mine T.
    Nihon Rinsho; 2006 Aug; 64(8):1483-6. PubMed ID: 16898617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Bouchoucha M, Devroede G, Bon C, Bejou B, Mary F, Benamouzig R.
    Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
    [Abstract] [Full Text] [Related]

  • 8. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR.
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [Abstract] [Full Text] [Related]

  • 9. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
    Zielińska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Małecka-Panas E, Wlaź P, Krajewska WM, Fichna J.
    J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402
    [Abstract] [Full Text] [Related]

  • 10. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K, Hazeena K, Thomas V, Kumar S, Jose T, Narayanan P.
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [Abstract] [Full Text] [Related]

  • 11. Colonic transit time and IBS symptoms: what's the link?
    Törnblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simrén M.
    Am J Gastroenterol; 2012 May; 107(5):754-60. PubMed ID: 22334251
    [Abstract] [Full Text] [Related]

  • 12. Calcium polycarbophil compared with placebo in irritable bowel syndrome.
    Toskes PP, Connery KL, Ritchey TW.
    Aliment Pharmacol Ther; 1993 Feb; 7(1):87-92. PubMed ID: 8439642
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit.
    Agrawal A, Houghton LA, Reilly B, Morris J, Whorwell PJ.
    Am J Gastroenterol; 2009 Aug; 104(8):1998-2004. PubMed ID: 19491831
    [Abstract] [Full Text] [Related]

  • 15. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [Abstract] [Full Text] [Related]

  • 16. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [Abstract] [Full Text] [Related]

  • 17. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.
    Bouchoucha M, Devroede G, Mary F, Bon C, Bejou B, Benamouzig R.
    Dig Dis Sci; 2018 Jul; 63(7):1763-1773. PubMed ID: 29492744
    [Abstract] [Full Text] [Related]

  • 18. Is the colonic response to food different in IBS in contrast to simple constipation or diarrhea without abdominal pain?
    Bouchoucha M, Devroede G, Raynaud JJ, Bon C, Bejou B, Benamouzig R.
    Dig Dis Sci; 2011 Oct; 56(10):2947-56. PubMed ID: 21479817
    [Abstract] [Full Text] [Related]

  • 19. Treatment of irritable bowel syndrome.
    Trinkley KE, Nahata MC.
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [Abstract] [Full Text] [Related]

  • 20. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M, Devroede G, Dorval E, Faye A, Arhan P, Arsac M.
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.